| Literature DB >> 24205150 |
Jamila Mejdoubi1, Silvia C C M van den Heijkant, Frank J M van Leerdam, Martijn W Heymans, Remy A Hirasing, Alfons A M Crijnen.
Abstract
BACKGROUND: Expectant mothers and mothers of young children are especially vulnerable to intimate partner violence (IPV). The nurse-family partnership (NFP) is a home visitation program in the United States effective for the prevention of adverse child health outcomes. Evidence regarding the effect of nurse home visiting on IPV is inconsistent. This study aims to study the effect of VoorZorg, the Dutch NFP, on IPV.Entities:
Mesh:
Year: 2013 PMID: 24205150 PMCID: PMC3804627 DOI: 10.1371/journal.pone.0078185
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Items and subscales of the Revised Conflict Tactics Scale.
Figure 2Flow of the participants through the study.
*General practitioners, gynecologists, midwives, street corner workers (comparable to social workers) etc. The number of women for stage 1 is unknown; the pilot studies indicate that the VoorZorg nurses selected approximately 50% of them.
† Only VoorZorg nurses could refer to the expert group, which settles arguments around inclusion .
§ No interviewer available, start-up problems RCT.
Numbers were only used for the 24-month analyses with imputated values.
Baseline characteristics of participants.
|
|
| |
|---|---|---|
|
| 19.2 (2.6) | 19.5 (2.8) |
|
| 19.6 (5.9) | 20.1 (6.5) |
|
| ||
|
| 147 (66) | 158 (67) |
|
| 76 (34) | 79 (33) |
|
| ||
|
| 110 (49) | 115 (49) |
|
| 13 (6) | 13 (6) |
|
| 58 (26) | 64 (27) |
|
| 42 (19) | 45 (19) |
|
| ||
|
| 7 (5) | 11 (6) |
|
| 150 (96) | 179 (94) |
|
| 36 (16) | 46 (19) |
|
| 49 (22) | 70 (30) |
|
| 40 (18) | 58 (24) |
|
| 74 (33) | 84 (35) |
|
| 40(18) | 46(19) |
|
| 9(4) | 12(5) |
Note. The information in Table 1 describes only those participants for whom data were available. Numbers are n (%) unless noted otherwise.
Prevalence of IPV by treatment condition at 32 weeks of pregnancy and 24 months after birth.
|
|
|
|
|
|
|---|---|---|---|---|
|
| ||||
|
| ||||
|
| 100% (110) | 100% (156) | - | - |
|
| 56% (61) | 39% (61) | 6 | 0.55 (0.32 to 0.94)**[ |
|
| ||||
|
| 58% (64) | 40% (62) | 6 | 0.38 (0.22 to 0.66)****[ |
|
| 31% (34) | 20% (31) | 9 | 0.57 (0.32 to 0.99)** |
|
| ||||
|
| 16% (18) | 8% (12) | 13 | 0.47 (0.19 to 0.90)** |
|
| 6% (7) | 7% (11) | - | 1.09 (0.41 to 2.92) |
|
| ||||
|
| 26% (28) | 16% (25) | 10 | 0.57(0.31 to 1.05) |
|
| 5% (5) | 5% (8) | - | 1.13 (0.36 to 3.56) |
|
| ||||
|
| 1.9; 1.06 | 1.7; 0.96 | -0.07 to 0.42 | |
|
| 31% (35) | 19% (29) | 8 | 0.49 (0.28 to 0.86)** |
|
| ( | ( | ||
|
| ||||
|
| 73% (162) | 74% (175) | - | 0.99 (0.50 to 1.95) |
|
| 47% (105) | 35% (83) | 8 | 0.63 (0.34 to 1.14) |
|
| ||||
|
| 44% (98) | 26% (62) | 6 | 0.46 (0.24 to 0.89)** |
|
| 25% (56) | 17% (40) | 12.5 | 0.63 (0.29 to 1.39) |
|
| ||||
|
| 15% (33) | 8% (19) | 14 | 0.49 (0.19 to 1.27) |
|
| 5% (11) | 8% (19) | - | 1.61 (0.38 to 6.68) |
|
| ||||
|
| 23% (51) | 16% (38) | 14 | 0.63 (0.25 to 1.56) |
|
| 9% (20) | 2% (8) | 14 | 0.22 (0.03 to 1.57) |
|
| ||||
|
| 1.6;0.19 | 1.3;0.12 | 0.32 (-0.70 to 0.06) | |
|
| 36% (80) | 23% (55) | 8 | 0.51 (0.21 to 1.25) |
Note. Multiple imputation analysis was conducted at 24 months after birth
NNT = numbers needed to treat over a 2-year time period
† Numbers are presented as the mean; Standard deviation
** p<0.05; *** p<0.005; **** p<0.001
# For explanation of levels 1 and 2: see Measurements in the Methods section
1 Adjusted for age and number of Sexually transmitted disease (STD) treatments
2 Adjusted for number of risk factors at baseline and number of STD treatments.
Prevalence of IPV by treatment condition at 32 weeks of pregnancy and 24 months after birth when participant is perpetrator.
|
|
|
|
|
|
|---|---|---|---|---|
|
| ||||
|
| ||||
|
| 87% (95) | 89% (139) | - | 1.59 (0.69 to 3.62) |
|
| 60% (66) | 46% (72) | 7 | 0.57 (0.35 to 0.94)** |
|
| ||||
|
| 65% (71) | 52% (81) | 8 | 0.57 (0.34 to 0.95)** |
|
| 33% (36) | 28% (43) | 20 | 0.78 (0.46 to 1.33) |
|
| ||||
|
| 6% (7) | 7% (11) | - | 1.10 (0.42 to 2.95) |
|
| 3% (3) | 1% (2) | 50 | 0.47 (0.08 to 2.84) |
|
| ||||
|
| 27% (30) | 17% (26) | 10 | 0.53 (0.29 to 0.96)** |
|
| 8% (9) | 10% (15) | - | 1.19 (0.51 to 2.85) |
|
| ||||
|
| 2.0; 0.97 | 1.7; 0.90 | 0.06 to 0.52** | |
|
| 31% (34) | 19% (30) | 8 | 0.53 (0.30 to 0.94)** |
|
| ( | ( | ||
|
| ||||
|
| 80% (178) | 76% (180) | 25 | 0.89 (0.38 to 2.09) |
|
| 39% (87) | 38% (90) | 100 | 0.97 (0.50 to 1.89) |
|
| ||||
|
| 48% (107) | 33% (78) | 7 | 0.54 (0.28 to 1.03) |
|
| 25% (56) | 14% (33) | 9 | 0.48 (0.22 to 1.05) |
|
| ||||
|
| 18% (40) | 3% (7) | 7 | 0.10 (0.02 to 0.56)*** |
|
| 5% (11) | 3% (7) | 50 | 0.60 (0.06 to 6.16) |
|
| ||||
|
| 24% (54) | 17% (40) | 14 | 0.63 (0.28 to 1.43) |
|
| 9% (20) | 8% (19) | 100 | 0.81 (0.29 to 2.31) |
|
| ||||
|
| 1.7;0.16 | 1.3;0.1 | - | 0.40 (-0.07 to -0.03)** |
|
| 33% (74) | 21% (50) | 8 | 0.56 (0.25 to 1.28) |
Note. Multiple imputation analysis was conducted at 24 months after birth
NNT = numbers needed to treat over a 2-year time period
Numbers are presented as the mean; Standard deviation
** p<0.05; *** p<0.005
For explanation of levels 1 and 2: see Measurements in the Methods section.